StageAcquired | Acquired
Provider of diagnostic systems for clinical microbiology. The company provides systems based on the bioluminescent detection of adenylate kinase, designed to enable the microbial detection and antibiotic sensitivity determination in hours instead of days, thereby reducing costs and hospital-acquired infections. [Keywords: methicillin-resistant staphylococcus aureus (MRSA)]
Missing: Acolyte's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Acolyte's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Acolyte Frequently Asked Questions (FAQ)
When was Acolyte founded?
Acolyte was founded in 2000.
Where is Acolyte's headquarters?
Acolyte's headquarters is located at Building 227, Salisbury.
What is Acolyte's latest funding round?
Acolyte's latest funding round is Acquired.
How much did Acolyte raise?
Acolyte raised a total of $13.46M.
Who are the investors of Acolyte?
Investors of Acolyte include Porton Capital, ANGLE Technology Ventures and Original Investments.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.